NASDAQ Companies

New contract adds to Evtec’s existing order book of $780 million Parts supplied by Evtec to be used in new […]

WARRINGTON, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company […]

BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) —  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in […]

NOVI, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North […]

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]

— Blinded data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in poster presentation — — […]

Highlights: Clarion’s Head of Psychiatry, Professor Suresh Sundram, has been approved by the TGA to prescribe MDMA for Post-traumatic Stress […]

– On track for PDUFA target action date of May 25, 2024 – CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) — […]

NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]

CINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware products and […]